ARTICLE – KEEPING UP TO DATE
mRNA – THE MEDICAL REVOLUTION? IAPCO Member: INTERPLAN, Germany In the wake of the ongoing Corona pandemic and the search
With the conference in full swing, the market maturity of
for promising measures to contain it, the topic of vaccination
BioNTech’s vaccine was announced, further boosting
is currently at the centre of public attention. Since 2019,
attention around the event. And more good news is in the
INTERPLAN has been proud to count among its clients some
pipeline, as CureVac also expects its vaccine to be approved
of the key players in the current debate, the companies
by summer 2021.
BioNTech, CureVac and Moderna, and thus the alignment of the International mRNA Health Conference.
The highly exciting topic of mRNA technology, which has
INTERPLAN was happy to facilitate a lively exchange
the potential to revolutionise medicine the way the iPhone
between speakers, around 700 attendees, and representatives
revolutionised communication, was the focus of the annual
from pharma and biotech companies by building a modern,
meeting at the beginning of November 2020. The digital
user-friendly and stable conference platform that covered the
conference, which usually alternates between Berlin and
stakeholder’s needs in a tailor-made manner.
Boston, provided a virtual yet no less imposing stage for leading experts to present and discuss cutting-edge research
“After the meeting is before the meeting, thus we are already
findings and recent experiences. Leading scientists and top
looking forward to preparing the next event in November 2021
virologists such as the internationally respected advisor to the
in Berlin, Germany - Let’s see what is new in the world of mRNA
U.S. government, Anthony Fauci, gave their contributions to
by then!”
the excellent quality and high relevance of the meeting.
| March 2021 23
